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Osmotic regulation of the Na1/myo-inositol cotransporter and postin- cific phospholipase C or phosphatidylinositol 3-kinase
duction normalization. [1–3]. Second, myo-inositol is an important osmolyte that
Background. In renal cells, hyperosmolarity has been shown to in-
protects cells exposed to hyperosmotic stress [4]. Thisduce the accumulation of myo-inositol, via the Na1/myo-inositol co-
transporter (SMIT). Previously we showed that SMIT mRNA in the protective role is shared with other osmolytes such as
kidney is localized in the medullary thick ascending limb of Henle sorbitol, betaine, taurine, and glycerophosphorylcholine;(TALH). Here we used renal cells derived from the rabbit outer medul-
however, these osmolytes may differ in their role aslary TALH to examine the regulation of myo-inositol transport by
hyperosmolarity. In addition, using both cultured renal and endothelial osmotic regulators because of their specific tissue local-
cells, we examined the normalization of SMIT activity and mRNA ization and mechanisms responsible for their accumula-levels following induction by hyperosmolarity.
tion/metabolism [5, 6].Methods. TALH cells were exposed to isotonic or hyperosmotic
medium, and then SMIT mRNA levels and myo-inositol accumulation In most mammalian cells, the intracellular concentra-
were determined. To examine postinduction normalization, cultured
tion of myo-inositol is maintained at levels many timesendothelial and renal cells were first exposed to hyperosmotic medium
and then to isotonic medium containing actinomycin D or cyclohexi- higher than circulating concentrations [7, 8]. This gradi-
mide. Afterwards, SMIT mRNA levels and myo-inositol accumulation ent is regulated and maintained by a Na1/myo-inositol
were determined.
cotransporter (SMIT) that is widely expressed in mam-Results. Hyperosmolarity increased SMIT mRNA levels and myo-
inositol accumulation in TALH cells. The hyperosmolarity-induced malian cells and by an efflux mechanism, which is poorly
increase in myo-inositol uptake by TALH cells was characterized by understood [9, 10]. In mammalian cells, hyperosmolarity
an increase in the Vmax for the high-affinity myo-inositol transport
is the most potent means to increase the activity of thesystem, with no change in the Km. This increase was blocked by actino-
mycin D or cycloheximide. Examination of postinduction normaliza- SMIT and thus myo-inositol accumulation [11–13]. The
tion showed that returning hyperosmotic-treated cells to isotonic me- hyperosmolarity-induced increase in myo-inositol trans-dium caused a rapid reversion of SMIT mRNA levels, followed by a
port is dependent on increased transcription of the SMITreturn of myo-inositol accumulation to basal values. However, the
addition of cycloheximide or actinomycin D partially to totally pre- gene [12]. Osmotic regulation of the organic osmolytes
vented the reversal in SMIT mRNA levels and activity. is physiologically important to renal cells; however, weConclusions. These results suggest that RNA and protein synthesis
and others have shown that hyperosmolarity also regu-is required for the hyperosmotic induction of SMIT mRNA levels and
myo-inositol accumulation by TALH cells. Furthermore, normalization lates SMIT activity and mRNA levels in endothelial,
of SMIT mRNA levels and myo-inositol accumulation following hyper-
neural, and glial cells [11, 13–16]. In addition, by in situosmotic induction requires RNA transcription and protein synthesis.
hybridization, we have previously localized SMIT mRNA
levels in the kidney and demonstrated that the medullary
thick ascending limb of Henle’s (TALH) loop was anMyo-inositol has at least two important functions in
important structure for the concentration of SMITmammalian cells. First, it has an integral role in signal
mRNA [5]. Therefore, we were interested in investigat-transduction pathways by virtue of its incorporation into
ing the osmotic regulation of SMIT mRNA levels andphosphoinositides and its subsequent release as second-
myo-inositol accumulation in cells derived from this re-ary messengers on activation of a phosphoinositide-spe-
gion of the kidney. In these studies, we demonstrate
that hyperosmolarity regulates SMIT mRNA and myo-Key words: hyperosmolarity, renal cells, cerebral microvessel endothe-
lial cells, transcription, SMIT. inositol accumulation in renal cells derived from the rab-
bit outer medullar TALH. Moreover, we show that the
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suggesting that normalization of SMIT activity and land, UK), respectively. The cells were derived from the
outer medulla of rabbit kidney and were transfected withmRNA levels following hyperosmotic induction is regu-
lated in mammalian cells. a plasmid pSV2-neoDNA (which contains the bacterial
gene neo, which confers resistance to the toxic antibiotic
G418) plus DNA from the early region of SV40 [17].
METHODS
The cells were grown in Dulbecco’s modified Eagle’s
Materials medium containing 10% heat-inactivated fetal bovine
serum, 294 mg/ml glutamine, and Geneticin (0.2 mg/ml).The chemicals were from Sigma (St. Louis, MO, USA)
unless otherwise noted. Ethanol, chloroform, isoamyl All cells were propagated in Corning 75 cm2 flasks in an
incubator maintained at 378C with 5% CO2 in humidifiedalcohol, Corning 75 cm2 flasks, and Falcon 6-well plates
were from Fisher Scientific (Fair Lawn, NJ, USA). Phenol air. Cells were passed weekly at a dilution ranging from
1:10 to 1:20 and were fed three times per week by replac-was from Bethesda Research Laboratories (Gaithersburg,
MD, USA). Ethidium bromide and proteinase K were ing the medium. For myo-inositol accumulation studies,
the cells were seeded onto Falcon six-well cluster plates,from Boehringher-Mannheim (Indianapolis, IN, USA).
Sodium dodecyl sulfate was from BDH (Poole, England, and assays were conducted in triplicate when the cells
reached confluence. For the mRNA studies, the cellsUK). Pyridine, trimethylchlorosilane, and hexamethyl-
disilazane were from Pierce (Rockford, IL, USA). Acryl- were seeded in Corning 75 cm2 flasks.
amide, bis-acrylamide, dextran sulfate, and N,N,N9,N9-
Myo-inositol accumulation and cellulartetramethylethylenediamine were from Biorad (Hercules,
myo-inositol determinationCA, USA) or Sigma. Transcription buffer, dithiothreitol,
RNasin, adenosine 59-triphosphate (ATP), cytidine 59- For myo-inositol accumulation determination, cells
were incubated in medium for 3 to 24 hours in the ab-triphosphate (CTP), uridine 59-triphosphate (UTP), gua-
nosine 59-triphosphate (GTP), T7 and SP6 RNA poly- sence or presence of 50 to 300 mm raffinose to induce
hyperosmolarity [11]. Afterward, the cells were washedmerase, and deoxyribonuclease were from Promega
(Madison, WI, USA). Myo-[2–3H]inositol and [32P]UTP with osmotically matched serum-free M199 medium and
were then incubated for up to 60 minutes in 2 ml ofwere from Amersham (Arlington Heights, IL, USA).
Safety-Solve, cesium chloride, and scintillation vials were this medium containing 0.5% bovine serum albumin and
myo-[2-3H]inositol. The myo-inositol concentration offrom RPI (Mount Prospect, IL, USA). A cDNA probe
for the b-actin gene of the rat and 18S rRNA was ob- the serum-free medium was 11.4 mm. After the incuba-
tion, cells were quickly washed two times with ice-coldtained from Ambion (Austin, TX, USA). Media were
obtained from the Diabetes Endocrinology Research 10 mm HEPES buffer, pH 7.4, containing 128 mm NaCl,
5.2 mm KCl, 2.1 mm CaCl2, 2.9 mm MgSO4, and 5 mmCenter, University of Iowa (Iowa City, IA, USA).
glucose and were collected by scraping the cells in 1.5
Cell culture ml water. The cell suspension was sonicated for 5 sec-
onds, and samples were taken to determine protein con-Murine MB114 cerebral microvessel endothelial
(CME) cells were obtained from Dr. Steven Moore, Uni- tent and myo-inositol accumulation. Myo-inositol accu-
mulation was determined by taking duplicate aliquotsversity of Iowa. The cells were grown in M199 medium
supplemented with 10% heat-inactivated fetal bovine of the cell suspension and measuring the radioactivity
present using a Beckman LS8100 liquid scintillationserum, 50 U/ml penicillin, 50 mg/ml streptomycin, and
basal media Eagle amino acid and vitamin solutions [11]. counter. Protein content was determined in duplicate
aliquots of the cell suspension using a modification ofBovine aortic endothelial cells originated from freshly
slaughtered steers and were grown in Dulbecco’s mini- the Lowry method [18]. Myo-inositol accumulation is
reported as nmol per mg protein. For many of thesemal essential medium supplemented with 10% heat-inac-
tivated fetal bovine serum, 100 U/ml penicillin, 100 mg/ studies, myo-inositol accumulation was determined fol-
lowing a one-hour incubation. In these studies, “myo-ml streptomycin, and 294 mg/ml glutamine [11]. Murine
cortical collecting duct and rat inner medullar collecting inositol accumulation” represents the cellular accumula-
tion of radioactivity derived from myo[2-3H]-inositol induct cells were kindly provided by Dr. John Stokes, Uni-
versity of Iowa, and were grown in Dulbecco’s minimal the medium during the incubation and does not repre-
sent the initial rate of myo-inositol transport by the cells.Eagle’s medium/F12 medium supplemented with 5%
heat-inactivated fetal bovine serum, 100 U/ml penicillin, It also does not account for any myo[2-3H]-inositol taken
up by the cells and then secreted during the one-hour100 mg/ml streptomycin, and 294 mg/ml glutamine [11].
Thick ascending limbs of Henle (TALH) cells were a incubation period. For the reversion studies, cells were
exposed to medium containing 150 mm raffinose (490kind gift from Drs. Kinne and MacDonald at the Max-
Planck-Institut for Molekulare Physiologie (Dortmund, mOsm) for 24 hours then were washed with isotonic
medium (,300 mOsm) and resuspended in isotonic me-Germany) and the University of Paisley (Glasgow, Scot-
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dium or this medium containing 5 mm actinomycin D verify elution times, and methyl a-D-mannopyranoside
or 25 mm cycloheximide for 6 to 24 hours. Afterwards, was added as an internal standard [11]. The myo-inositol
myo-inositol accumulation was determined as described and sorbitol content was calculated as nmol/mg of cell
above. For these studies, myo-inositol accumulation was protein.
also determined in cells maintained in isotonic medium
Quantitation of SMIT mRNA levelsor exposed for 24 hours to hypertonic medium. Cell
viability was verified by demonstrating exclusion of try- Na1/myo-inositol cotransporter mRNA levels in
pan blue and the continued adherence of the cells to CME, cortical collecting duct, and TALH cells were
the culture plate. In addition, 51Cr release studies were quantitated using a solution hybridization-RNase protec-
conducted to assure that changes in hyperosmolarity did tion assay as previously described [11]. Briefly, [32P]-
not reduce cellular viability. 51Cr release studies were labeled antisense SMIT mRNAs were transcribed using
conducted according to the method of Thorne et al [19]. T7 RNA polymerase and a murine SMIT cDNA con-
For these studies, cells were prelabeled with 51Cr for two struct in pGEM-3Zf(1) that had been linearized with
hours, were washed with normal medium, and were then Hind III. For the inner medullar collecting duct cells,
exposed to either isotonic medium, hypertonic medium,
[32P]-labeled antisense SMIT mRNAs were transcribed
or isotonic medium containing 1% Triton X-100 for one
using SP6 RNA polymerase and a rat SMIT cDNA con-hour. Then the medium was examined for radioactivity.
struct in pGEM-3Zf(1) that had been linearized withResults from this study with each of the cell lines indi-
EcoR1 [5]. Details of the cloning of the murine and ratcated that exposing the cells for one hour to hyperos-
SMIT cDNAs have been described previously [5, 11].motic medium had absolutely no effect on 51Cr release
The murine SMIT cDNA binds to a 185 nucleotide frag-from the cells compared with cells exposed to isotonic
ment, and the rat SMIT cDNA binds to a 363 nucleotidemedium (data not shown).
fragment. For these studies, because of the high degree ofTo determine the effect of sodium on myo-inositol
homology of the SMIT gene, the [32P]-labeled antisenseuptake by TALH cells, cells were incubated in HEPES
murine SMIT mRNA probe was hybridized with rabbitbuffer containing 10 mm myo-[2-3H]inositol for 10 min-
RNA to give a protected band similar in size to RNAutes. For Na1-independent myo-inositol uptake determi-
derived from murine cells. Antisense SMIT mRNAsnation, the cells were washed and incubated in this buffer
were incubated at 458C in 75% formamide-0.4 m NaClcontaining choline chloride in place of NaCl. Kinetic
with 20 mg of total RNA. After 16 hours of incubation,parameters for high-affinity myo-inositol transport were
determined by incubating cells for five minutes in the samples were digested with RNases A and T1. The
HEPES buffer with or without NaCl and containing 5 protected double-stranded hybrids were collected by eth-
to 250 mm myo-[2-3H]inositol as previously described anol precipitation and electrophoresed through an 8%
[11]. Uptake of myo-inositol occurring in the absence of polyacrylamide-8 m urea denaturing gel. To confirm
NaCl was subtracted from uptake in the presence of equal loading of the gel, 18S ribosomal RNA or b-actin
NaCl before determining the apparent (indicated by the mRNA was determined simultaneously with the use of
apostrophe) K’m and V’max for high-affinity myo-inositol a commercially available 18S antisense control template,
transport [11]. which binds to an 80-nucleotide fragment from a con-
To determine the effect of hyperosmolarity on the served region of the 18S ribosomal RNA or a b-actin rat
intracellular myo-inositol and sorbitol content, TALH antisense control template that binds to a 127 nucleotide
cells were grown in 25 cm2 flasks to confluence and were fragment of b-actin mRNA. The antisense 18S and b-
then incubated in serum-free medium in the absence or actin RNAs were generated per the manufacturer’s in-
presence of 150 mm raffinose for 24 hours. Afterward,
structions using T7 polymerase. A sufficient quantity of
the cells were washed with glucose-free HEPES buffer,
each of the antisense SMIT mRNA, b-actin, and 18Scollected in water, and sonicated. Aliquots of the cell
rRNA probes was added to each sample to insure thesuspension were taken for protein determination and
presence of an excess of labeled antisense RNA [11].derivatization as described previously [11]. The deriva-
SMIT mRNAs were represented as a single band on thetized samples were then chromatographed on a tempera-
autoradiogram of the gel, with the intensity of the bandture-programmed Hewlett-Packard 5890 gas chromato-
being proportional to the SMIT mRNA level in the sam-graph interfaced with a model HP3390A integrator. The
ple. SMIT mRNA levels were quantitated by scanninginitial temperature of 1808C was maintained for two min-
densitometry of the autoradiogram using a GS 300 trans-utes and was then increased at 48C/minute to a final
mittance/reflectance scanning densitometer (Hoefer,temperature of 2258C, which was maintained for five
San Francisco, CA, USA) interfaced with a model HPminutes. The column consisted of 3% SE-30 on Supelco-
3396A integrator and standardized to the intensity ofport (Supelco, Bellefonte, PA, USA). An authentic stan-
dard containing myo-inositol and sorbitol was run to the 18S rRNA or b-actin mRNA band.
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Fig. 1. Effect of hypertonicity on myo-inositol
accumulation by TALH cells. Cells were incu-
bated for 16 hours in isotonic medium ( ) or
medium containing 150 mm raffinose ( ); 490
mOsm). Afterwards, myo-inositol accumulation
was determined as described in the Methods sec-
tion by incubating the cells for 5 to 60 minutes
in serum-free medium containing 0.5% bovine
serum albumin and myo-[2– 3H]inositol. Data are
expressed as the mean 6 sem for four separate
determinations conducted in triplicate. *P , 0.05,
compared to untreated cells.
Data analysis tion of myo-inositol accumulation by TALH cells at the
later time points is unknown. TALH cells have a largeData for myo-inositol accumulation are reported as
metabolic capacity for myo-inositol, including a largenmol per milligram cell protein or as a percentage of
intracellular-free myo-inositol pool and vigorous incor-the control. Myo-inositol and sorbitol content data are
poration of myo-inositol into phosphoinositides. It is pos-presented as nmol per milligram cell protein. Significance
sible that as myo-[2-3H]inositol is distributed into theseof differences was determined by analysis of variance
different pools, following its initial uptake, that myo-[2-and Student’s t-test. For analysis of SMIT mRNA levels,
3H]inositol turnover may vary, giving the appearancestatistical comparisons for significance were performed
that myo-inositol uptake increases with a longer incuba-using the one-tailed multiple comparison procedure of
tion period. The apparent induction of myo-inositol ac-Dunnett.
cumulation observed following a 30- to 60-minute incu-
bation may become less dramatic if the incubation period
RESULTS is extended to 6 to 24 hours, which would allow enough
Effect of hyperosmolarity on myo-inositol time for the myo-[2-3H]inositol taken up to equilibrate
accumulation and SMIT mRNA levels in TALH cells within the cell. However, this is only one interpretation
of these data, and other explanations may be possible.Previously, we and others have shown that SMIT
We have also determined that the accumulation ofmRNA in the outer medulla was predominantly local-
myo-inositol by TALH cells is completely Na1 depen-ized to the medullar TALH loop [5, 20]. Therefore, we
dent. Incubating normal or hyperosmotic-exposed cellsexamined the effect of hyperosmolarity on myo-inositol
in a Na1-free HEPES buffer containing 10 mm myo-[2-accumulation and SMIT mRNA levels in TALH cells
3H]inositol for 10 minutes reduced myo-inositol accumu-derived from the outer medulla of rabbit kidney [17].
lation by more than 95% compared with cells incubatedData in Figure 1 show a time course (5 to 60 minutes)
in normal HEPES buffer (data not shown). Data in Fig-for myo-inositol accumulation by TALH cells after a 16-
ures 2 and 3 show the effect of increasing osmolarityhour incubation in isotonic or hypertonic medium (150
(,300 to 590 mOsm) and time of exposure (0.5 to 24 hr)mm raffinose, 490 mOsm). The accumulation of myo-
on myo-inositol accumulation and SMIT mRNA levels,inositol was linear in isotonic cells during the initial 30
respectively, by TALH cells. Exposing the cells for 16minutes of the incubation period and then apparently
hours to 50 to 300 mm raffinose caused an osmolarity-accelerated. Accumulation of myo-inositol by hyperos-
dependent increase in myo-inositol accumulation andmotic treated cells was linear for the initial 10 minutes
SMIT mRNA levels. A maximum effect on myo-inositolof the incubation period (insert, Fig. 1) and was then
accumulation and SMIT mRNA levels was observedaccelerated. At all time points, myo-inositol accumula-
with 200 mm raffinose (490 mOsm) following a 12-hourtion was significantly increased following exposure to
hyperosmotic medium. The reason for the unusual induc- incubation. Data in Figures 2 and 3 show that hyperos-
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Fig. 2. Concentration and time course analysis of
the effect of hyperosmolarity on myo-inositol accu-
mulation by TALH cells. Cells were incubated for
16 hours in medium containing 50–300 mm raffinose
(,300–590 mOsm) or in medium containing 200 mm
raffinose (490 mOsm) for 0.5 to 24 hours. Afterwards,
myo-inositol accumulation was determined as de-
scribed in the Methods section by incubating the cells
for one hour in serum-free medium containing 0.5%
bovine serum albumin and myo-[2– 3H]inositol. Data
are expressed as the mean 6 sem for six separate
determinations conducted in triplicate. *P , 0.05,
compared to untreated cells.
Fig. 3. Representative autoradiograph of the effect of
hypertonicity on levels of SMIT mRNA and 18S rRNA
in TALH cells. Cells were incubated for 16 hours in
medium containing 50 to 300 mm raffinose (,300 to 590
mOsm) or in medium containing 200 mm raffinose (490
mOsm) for 0.5 to 12 hours. Afterwards, RNA was iso-
lated, and SMIT mRNA and 18S rRNA levels deter-
mined by RNase protection assay as described in the
Methods section.
molarity induction of SMIT mRNA levels precedes the and myo-inositol content was significantly increased to
15.4 6 1.7 and 336.0 6 25 nmol/mg protein, respectivelyincrease in myo-inositol accumulation by TALH cells.
The level of 18S rRNA was unchanged by hypertonicity. (P , 0.05).
K’m and V’max for high-affinity myo-inositol transportExposing TALH cells for 24 hours to hypertonic medium
(200 mm raffinose) caused a significant increase in the were calculated to determine whether the hypertonicity-
induced increase in myo-inositol accumulation by TALHintracellular sorbitol and myo-inositol content. The sor-
bitol and myo-inositol content of TALH cells after incu- cells was due to a change in myo-inositol transporter
affinity or to an increase in the number of myo-inositolbation in normal or isotonic medium was 5.0 6 0.7 and
165.3 6 18 nmol/mg protein, respectively (N 5 12). After transporters on the plasma membrane. Kinetic analysis
of high-affinity transport by TALH cells was conducted,a 24-hour incubation in hypertonic medium, the sorbitol
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Table 1. Effect of cycloheximide or actinomycin D on hypertonicity-induced accumulation of myo-inositol by TALH cells
Cycloheximide Actinomycin D
2 1 2 1
Control 0.66 6 0.02 0.80 6 0.02 0.30 6 0.01 0.28 6 0.01
Hyperosmolarity 3.08 6 0.33ab 0.64 6 0.04 1.36 6 0.04ab 0.21 6 0.01
Thick ascending limb of Henle (TALH) cells were preincubated in isotonic medium with or without cycloheximide (25 mm) or actinomycin D (5 mm) for one hour
prior to the induction of hyperosmolarity (200 mm raffinose | 490 mOsm). The cells were then incubated for 16 hours, and, afterwards, myo-inositol accumulation
was determined by incubating the cells for one hour in serum-free medium containing 0.5% bovine serum albumin and myo-[2-3H]inositol. The final concentration
of myo-inositol in the medium was 11.4 mm. myo-inositol accumulation is expressed as the mean 6 sem for six separate determinations conducted in triplicate.
a P , 0.05 compared to control
b P , 0.05 compared to cycloheximide or actinomycin D treated cells, respectively
as previously described, by incubating the cells in buffer
with or without Na1 for five minutes containing 0 to 250
mm myo-inositol [11]. The uptake of myo-inositol by the
cells incubated in buffer without Na1 was subtracted
from the uptake of myo-inositol by cells incubated in
buffer with Na1. A five-minute uptake period was se-
lected for these studies because the accumulation of
myo-[2-3H]inositol after a five-minute incubation was lin-
ear for both isotonic and hyperosmotic treated cells (in-
sert, Fig. 1). This time period also avoided the unex-
plained induction of myo-inositol accumulation, which
Fig. 4. Representative autoradiograph of the effect of actinomycin Dis apparent during later time points (Fig. 1). Background
or cycloheximide on the induction of SMIT mRNA levels by hyperos-studies for myo-inositol uptake by TALH cells demon-
molarity in TALH cells. Cells were preincubated in serum-free medium
strated that after a five-minute incubation period, myo- containing 5 mm actinomycin D or 25 mm cycloheximide for one hour
prior to the induction of hypertonicity. After 12 hours, RNA was iso-inositol uptake is saturated at an extracellular myo-inosi-
lated, and SMIT mRNA levels determined by RNase protection assaytol concentration of approximately 1 mm (data not
as described in the Methods section.
shown). Like many other cell types, TALH cells have a
low- and high-affinity myo-inositol transport system
(data not shown) [21]. The low-affinity transport system
is Na1 independent and is apparent at nonphysiological mycin D but not by cycloheximide (Fig. 4). These data
concentrations of myo-inositol, whereas the high-affinity suggest that the hyperosmolarity-induced increase in
transport system is Na1 dependent and dominates at myo-inositol transport requires protein synthesis and
physiological concentration of myo-inositol. For these transcriptional activation of the SMIT gene, whereas the
studies, cells were incubated in isotonic or hypertonic increase in SMIT mRNA levels is dependent on only
medium (200 mm raffinose, ,490 mOsm) for 16 hours RNA synthesis [11, 12].
prior to the analysis of high-affinity myo-inositol trans-
Postinduction normalization of hyperosmolarity-inducedport. Results from eight separate studies showed that
myo-inositol accumulation and SMIT mRNA levelsthe K’m and V’max were 104.3 6 24.5 mm and 230.2 6 38.0
pmol/min/mg protein, respectively, for cells incubated in Several studies have shown that the reversal of the
isotonic medium and 103.6 6 25.3 mm and 711.4 6 77.2 hyperosmolarity-induced increase in myo-inositol accu-
pmol/min/mg protein (P , 0.01), respectively, for cells mulation occurs within hours after the removal of the
incubated in hypertonic medium. These results are con- hyperosmotic condition [11, 14–16]. This was confirmed
by studies presented in Table 2, which show that within 6sistent with the hypertonicity-induced increase in SMIT
mRNA levels in TALH cells and suggest that the number to 12 hours after removal of the hyperosmotic condition,
myo-inositol accumulation by cultured renal and endo-of myo-inositol transporters on the plasma membrane
of TALH cells is increased by exposing the cells to hyper- thelial cells is significantly reduced compared with the
myo-inositol accumulation by cells in hyperosmotic con-tonic medium.
Data in Table 1 show that the hyperosmolarity- ditions and by 48 hours has returned to basal levels.
These studies indicate that turnover of the SMIT occursinduced increase in myo-inositol accumulation by TALH
cells is significantly inhibited by cycloheximide and acti- relatively rapidly; however, little is known about the
regulation of this process.nomycin D. In TALH cells, the hyperosmolarity-induced
increase in SMIT mRNA levels was blocked by actino- In the following studies, we examined the effect of
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Table 2. Post-induction normalization of myo-inositol accumulation by cultured renal and endothelial cells following hyperosmotic induction
Cells
% of control
Conditions TALH IMCD CCD BAE CME
Hyperosmolarity 1016 6 15a 349 6 58a 461 6 25a 863 6 84a 968 6 25a
Reversion
6 hours 731 6 20ab 371 6 69a 488 6 7a 326 6 14ab 866 6 57ab
12 hours 441 6 6ab 271 6 55a 276 6 14ab 245 6 12ab 298 6 5ab
24 hours 209 6 3ab 262 6 62a 149 6 8b 207 6 15b 95 6 7b
48 hours 104 6 4b 102 6 11b 111 6 1b 117 6 7b 89 6 3b
Cultured cells were exposed to hyperosmotic medium containing 150 mm raffinose for 24 hours. Afterwards, the cells were washed and incubated for 6 to 48 hours
in isotonic medium. After these incubations, myo-inositol accumulation was determined by incubating the cells for one hour in serum-free medium containing 0.5%
bovine serum albumin and myo-[2-3H]inositol. The final concentration of myo-inositol in the medium was 11.4 mm. myo-inositol accumulation (mean 6 sem) is
expressed as the percent of control. For these studies, the accumulation of myo-inositol by cells maintained in isotonic medium was 0.41 6 0.01 (N 5 3), 0.34 6 0.03
(N 5 6), 0.11 6 0.01 (N 5 3), 0.36 6 0.03 (N 5 6), and 0.89 6 0.06 (N 5 6) nmol/mg protein for thick ascending limb of Henle (TALH), inner medullar collecting
duct (IMCD), cortical collecting duct (CCD), arota endothelial (BAE), and cerebral microvessel endothelial (CME) cells, respectively.
a P , 0.05, compared to control
b P , 0.05, compared to hyperosmolarity-induced cells
Table 3. Effect of actinomycin D and cycloheximide on post-induction normalization of myo-inositol accumulation by cultured renal and
endothelial cells following hyperosmotic induction
Cells
TALH IMCD CCD BAE CME
Conditions (14) (14) (9) (15) (12)
Control 0.70 6 0.07 0.35 6 0.03 0.12 6 0.01 0.36 6 0.02 1.48 6 0.17
Hyperosmolarity 2.13 6 0.18ab 0.76 6 0.08ab 0.65 6 0.07ab 2.17 6 0.40ab 5.78 6 0.53ab
Reversion
Isotonic 1.37 6 0.13a 0.40 6 0.05 0.28 6 0.04 0.74 6 0.08a 2.30 6 0.23
Isotonic 1 actinomycin D 2.79 6 0.21ab 0.86 6 0.06ab 1.80 6 0.16ab 2.08 6 0.41ab 6.71 6 0.78ab
Isotonic 1 cycloheximide 2.52 6 0.13ab 1.06 6 0.05ab 1.97 6 0.24ab 1.86 6 0.24ab 3.93 6 0.30ab
Cells designated to be used in the reversion studies were incubated for 24 hours in hyperosmotic medium containing 150 mm raffinose. Afterwards, the cells were
washed with isotonic medium, then resuspended in isotonic medium or this medium containing 5 mm actinomycin D or 25 mm cycloheximide for either 16 hours
[cortical collecting duct (CCD), inner medullary collecting duct (IMCD), or cerebral microvessel endothelial (CMD) cells] or 24 hours [thick ascending limb of Henle
(TALH) or aorta endothelial (BAE) cells]. Control cells were incubated continuously in isotonic medium, and cells exposed to hyperosmotic conditions were
incubated in medium containing 150 mm raffinose for 24 hours prior to determination of myo-inositol accumulation. After these incubations, myo-inositol accumulation
was determined by washing the cells with serum-free medium and then incubating the cells for one hour in this medium containing 0.5% bovine serum albumin and
myo-[2-3H]inositol. The final concentration of myo-inositol in the medium was 11.4 mm. myo-inositol accumulation (nmol/mg protein) is expressed as the mean 6
sem for the number of determinations indicated in the parentheses.
a P , 0.05 compared to control
b P , 0.05 compared to hyperosmolarity-induced cells returned to isotonic medium
cycloheximide and actinomycin D on the reversion of medium for 24 hours caused a significant increase in
myo-inositol accumulation. Returning cells exposed tohyperosmolarity-induced SMIT mRNA levels and myo-
inositol accumulation using cultured renal and endothe- hyperosmotic medium to isotonic medium for 16 to 24
hours caused a significant reduction in myo-inositol accu-lial cells. The concentrations of cycloheximide and acti-
nomycin D used in these studies were shown to block mulation, which approached basal levels. However, if
either actinomycin D (5 mm) or cycloheximide (25 mm)protein synthesis and gene transcription, respectively
(data not shown). For these studies, the cells were ex- is added to the isotonic medium, myo-inositol accumula-
tion remains elevated and is significantly greater thanposed to 150 mm raffinose for 24 hours. Afterwards, the
cells were washed and resuspended in isotonic medium the myo-inositol accumulation observed in cells preincu-
bated in hyperosmotic medium and returned to isotonicor this medium containing 5 mm actinomycin D or 25 mm
cycloheximide for 16 to 24 hours, and then the SMIT medium for 16 to 24 hours. Data in Figure 5 show that
SMIT mRNA levels were significantly elevated in eachmRNA levels and myo-inositol accumulation were de-
termined. Cells incubated for 24 hours in isotonic me- of the cell types after a 24-hour exposure to hyperosmotic
medium (condition 2), and they returned to near basaldium or in this medium containing 150 mm raffinose were
used to determine basal or hyperosmolarity-induced levels after returning the hyperosmolarity-induced cells
to isotonic medium for six hours (condition 3). Adding 5SMIT mRNA levels and myo-inositol accumulation.
Data in Table 3 show that exposing each of the five mm actinomycin D (condition 4) or 25 mm cycloheximide
(condition 5) to the isotonic medium partially to com-different renal or endothelial cell types to hyperosmotic
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Fig. 5. Effect of actinomycin D or cycloheximide on the post-induction
normalization of SMIT mRNA levels in cortical collecting duct (A),
cerebral microvessel endothelial (B), inner medullary collecting duct
(C) and thick ascending limb of Henle (D) cells. Cells were incubated
as described in Table 3. After a six hour incubation, RNA was isolated
and SMIT mRNA levels determined by RNase protection as described
in the Methods section. The relative abundance of SMIT mRNA in
control cells maintained in isotonic medium was arbitrarily assigned a
value of 1. All values were normalized using b-actin mRNA or 18S
rRNA levels. *P , 0.05, compared to SMIT mRNA levels in control
cells. 1P , 0.05, compared to SMIT mRNA levels in hyperosmolarity-
induced cells returned to isotonic medium for 6 hours.
pletely blocked the reversion of SMIT mRNA levels in
all four cell types examined. Figure 6 is a representative
autoradiograph showing SMIT mRNA levels and either
18S rRNA or b-actin mRNA levels as a control for each
of the cell types examined.
Fig. 6. Representative autoradiograph of the effect of actinomycin D
DISCUSSION or cycloheximide on the post-induction normalization of SMIT mRNA
levels in cortical collecting duct (CCD), cerebral microvessel endothelialCells react to increased osmolarity with numerous (CME), inner medullary collecting duct (IMCD) and thick ascending
changes in gene expression. The specific genes affected limb of Henle (TALH) cells.
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differ between species, but the known osmoprotective isotonic medium. We and others have also shown that
SMIT mRNA levels revert to normal levels within foureffects of the gene products are remarkably similar, par-
ticularly with regard to cellular accumulation of compati- to six hours after cells stimulated with hyperosmotic me-
dium are returned to an isotonic medium [11, 16]. Thisble organic osmolytes [22]. These studies show that cells
derived from the outer medullar TALH, like other mam- suggests that down-regulation of transporter activity oc-
curs relatively slowly compared with SMIT mRNA lev-malian cells, increase SMIT mRNA levels and myo-inosi-
tol accumulation following exposure to hyperosmotic els. Presumably, this rapid reduction in SMIT mRNA
levels reflects rapid inhibition of gene transcription instress [11–13]. Grunewald et al have shown that choline
transport by these cells is up-regulated by hyperosmolar- response to a decrease in cell osmolarity and/or a change
in mRNA stability. Our studies demonstrate that theity [23]. Similar to the effect of hyperosmotic stress on
the choline transport system, the V’max for the high-affin- reversion of the hyperosmolarity-induced increase in
SMIT mRNA levels and myo-inositol accumulation toity myo-inositol transporter was significantly increased
by hyperosmolarity with little change in the K’m. In addi- basal levels following the return of cells to isotonic me-
dium is sensitive to RNA and protein synthesis. Actino-tion, our studies showed that sorbitol accumulation by
TALH cells is increased following exposure to hyperos- mycin D and cycloheximide prevented the reversion of
myo-inositol accumulation to basal levels after cellsmotic medium. Thus, these studies demonstrate that
TALH cells, after exposure to hyperosmotic stress, up- treated with hyperosmotic medium were returned to iso-
tonic medium. Moreover, the return of SMIT mRNAregulate transport and synthetic pathways to increase
the production and/or uptake of the organic osmolytes, levels to basal levels under these conditions was partially
prevented by actinomycin D and cycloheximide. Theseglycerophosphorylcholine, sorbitol, and myo-inositol
[23]. However, as our studies also show, myo-inositol data suggest that reversion of SMIT mRNA levels to
basal levels is not secondary to the extinction of hyperos-accumulation by TALH cells is several-fold greater than
sorbitol accumulation, suggesting that myo-inositol may molarity-induced changes in SMIT gene transcription
and/or mRNA stability. Rather, reversion appears to bebe the predominant osmolyte in these cells. This would
agree with previous in vivo studies of renal SMIT distri- an active and possibly regulated process that is depen-
dent on both RNA and protein synthesis. Certainly, therebution, which demonstrated that the TALH loop is the
major site of localization of SMIT mRNA in the kidney is a precedent for protein binding to the 39 untranslated
region of mRNAs regulating mRNA stability. For exam-[5, 20].
In other renal cell types, the effect of hyperosmolarity ple, tumor necrosis factor-a destabilizes endothelial ni-
tric oxide synthase mRNA by increasing the activity ofon SMIT gene expression is at the level of gene transcrip-
tion [12]. Our data are consistent with the hyperosmolar- cytosolic proteins that destabilize endothelial nitric oxide
synthase mRNA by binding to its 39 untranslated regionity-induced increase in SMIT gene expression in TALH
cells being mediated at the level of gene transcription [28]. Interestingly, we have shown that tumor necrosis
factor-a causes a decrease in SMIT mRNA levels andbecause actinomycin D prevented the increase in SMIT
mRNA levels. Like the genes encoding the betaine trans- transporter activity by an unexplained mechanism in en-
dothelial cells [29]. One possibility for our findings isporter and aldose reductase, the SMIT gene has recently
been shown to have an osmolarity-responsive promoter that the return of cells to isotonic medium induces the
transcription of a gene that encodes a protein, whichthat likely contributes to the increase in SMIT mRNA
levels and myo-inositol accumulation following osmotic binds to and destabilizes SMIT mRNA. Our data, how-
ever, do not rule out the alternative possibility that cellsstress [24–27]. From these studies we conclude that
TALH cells, like other renal cells, are highly responsive produce a factor after return to isotonic medium that
represses expression of the SMIT gene. Further studiesto osmotic stress and rapidly initiate pathways leading
to the accumulation of organic osmolytes, and that myo- will be required to address this issue. Moreover, our
studies show that the reversion of myo-inositol accumu-inositol may be the primary osmolyte for this region of
the kidney. lation to basal levels following the transfer of cells from
hyperosmotic to isotonic medium is completely blockedReversion of myo-inositol accumulation to a value not
significantly different than control cells maintained in by cycloheximide and actinomycin D. In some cell types,
the uptake of myo-inositol is even greater in cells trans-isotonic conditions following removal of a hyperosmotic
stimulus occurs within 16 to 48 hours, as evidenced by ferred from hyperosmotic medium to isotonic medium
containing actinomycin D or cycloheximide comparedstudies of several renal cell types, brain glial cells, CME
cells, and neuroblastoma cells [11, 14–16]. The studies with cells maintained in hyperosmotic medium. The rea-
son for this difference is unknown. These data suggestpresented in Table 2 provide additional evidence that
reversion of myo-inositol accumulation to basal levels that SMIT protein turnover is blocked by these condi-
tions and that myo-inositol accumulation is maintainedoccurs within 24 to 48 hours after renal or endothelial
cells treated with hypertonic medium are returned to an or even increased compared with myo-inositol accumula-
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levels and myo-inositol uptake by osmolarity in cultured endothe-tion by cells treated with hyperosmotic medium.
lial and neural cells. Am J Physiol 270:C990–C997, 1996
Whether this effect can be explained solely by a regula- 12. Yamauchi A, Uchida S, Preston AS, Kwon HM, Handler JS:
Hypertonicity stimulates transcription of gene for Na1-myo-inosi-tion of changes in SMIT mRNA levels or whether
tol cotransporter in MDCK cells. Am J Physiol 264:F20–F23, 1993changes in SMIT internalization and/or degradation also
13. Strange K, Morrison R, Heilig CW, Dipietro S, Gullans SR:
contribute to the normalization of SMIT activity when Upregulation of inositol transport mediates inositol accumulation
in hyperosmolar brain cells. Am J Physiol 260:C784–C790, 1991cells are returned to isotonic medium from hyperosmotic
14. Veis JH, Molitoris BA, Teitelbaum I, Mansour JA, Berl T:conditions remains to be determined. Myo-inositol uptake by rat cultured inner medullary collecting
tubule cells: Effect of osmolarity. Am J Physiol 260:F619–F625,In summary, expression of the SMIT in TALH cells
1991is regulated by hyperosmolarity in a similar manner to
15. Miyai A, Yamauchi A, Nakanishi T, Sugita M, Takamitsu Y,
other cells. Interestingly, these studies have demon- Yokoyama K, Itoh T, Andou A, Kamada T, Ueda N, Fujiwara
Y: Na1/myo-inositol cotransport is regulated by tonicity in culturedstrated the novel finding that the normalization of SMIT
rat mesangial cells. Kidney Int 47:473–480, 1995mRNA levels and myo-inositol transport after loss of the 16. Paredes A, McManus M, Kwon HM, Strange K: Osmoregulation
hyperosmotic stimulus requires both protein and RNA of Na1-inositol cotransporter activity and mRNA levels in brain
glial cells. Am J Physiol 263:C1282–C1288, 1992synthesis.
17. Scott DM, MacDonald C, Brzeski H, Kinne R: Maintenance
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